Skip to main content
2023 ACCP Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Clinical Drug Development & Investigations

Symposium 13: Clinical Pharmacology Challenges in Obesity & Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Mechanisms & Therapeutics

5 - Use of Physiologically-based Pharmacokinetic Modeling to Advance Clinical Trials in Obesity & NAFLD/NASH

Tuesday, September 12, 2023
1:30 PM - 3:00 PM PT
Disclosure(s):
Yurong Lai, PhD: Gilead sciences Inc: Employment (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) ()